Expanded FDA approval of Phathom Pharmaceuticals drug Voquezna now includes patients with non-erosive gastroesophageal reflux disease (GERD). Phathom licensed its flagship product from Takeda Pharmaceutical.
EndoGastric Solutions' well funded TIF procedure is meant to improve acid reflux issues in those with serious GERD.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
EndoGastric Solutions has raised more than $160 million for its device that one-ups laparoscopy - it helps surgeons conduct stomach surgery through the mouth, so no incisions need to be made.
Researchers and medical device companies are using electrical stimulation in new products to address pain, sleep apnea, paralysis and ALS. But a young St. Louis company is applying electrical stimulation to gastroesophageal reflux disease to reduce the need for treatment with proton pump inhibitors. EndoStim has already secured European approval to market its implantable electrical […]